Department of Radiology, the University of Vermont Medical Center, Burlington, VT, USA.
Department of Neurosurgery, the Massachusetts General Hospital, Boston, MA, USA.
Interv Neuroradiol. 2020 Jun;26(3):358-363. doi: 10.1177/1591019919898923. Epub 2020 Jan 22.
We describe our initial experience with the React 68 catheter (Medtronic, Dublin, Ireland), an FDA-approved catheter designed for aspiration in cases of emergent large vessel occlusion, as compared with the ACE 68 catheter (Penumbra, Alameda, CA).
This observational study followed consecutive patients treated with the React catheter over a seven-month period at a comprehensive stroke center. Use of the device was per discretion of the operator. Patient demographics, thrombectomy technique, reperfusion scoring, and disposition were assessed. Performance was compared with patients treated with the ACE 68 catheter over a comparable period.
We treated 47 patients using the React 68 catheter using either aspiration alone or a combination of aspiration and stent retriever technique. The catheter was used in a variety of circumstances including proximal and distal occlusions involving the anterior and posterior circulation. Modified TICI 2b-3 was achieved in 45 of the 47 patients. The React 68 was comparable to the ACE 68 by all performance measures.
The React 68 catheter is a large-bore reperfusion catheter with trackability suitable for use in direct aspiration for recanalization of emergent large vessel occlusion.
我们介绍了我们在使用 React 68 导管（美敦力，都柏林，爱尔兰）方面的初步经验，这是一种经过 FDA 批准的导管，设计用于在紧急大血管闭塞时进行抽吸，与 ACE 68 导管（Penumbra，阿拉米达，加利福尼亚州）进行比较。
这项观察性研究在一个综合性卒中中心对在七个月期间接受 React 导管治疗的连续患者进行了随访。该设备的使用由操作者决定。评估了患者的人口统计学特征、血栓切除术技术、再灌注评分和处置情况。将其与在可比时间段内接受 ACE 68 导管治疗的患者进行了比较。
我们使用 React 68 导管治疗了 47 例患者，单独使用抽吸或抽吸和支架回收器技术联合使用。该导管用于多种情况，包括涉及前循环和后循环的近端和远端闭塞。在 47 例患者中的 45 例中实现了改良 TICI 2b-3。在所有性能指标上，React 68 导管均与 ACE 68 导管相当。
React 68 导管是一种大口径再灌注导管，具有可追踪性，适用于直接抽吸以再通紧急大血管闭塞。
